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Abstract
Introduction Proteomic characterization of the human pan-
creatic islets, containing the insulin producing beta-cells, is
likely to be of great importance for improved treatment and
understanding of the pathophysiology of diabetes mellitus.
Objective The focus of this study was to characterize the
human islet membrane proteome.
Methods In order to identify as many membrane proteins as
possible, five different extraction procedures were used,
i.e., phase separation using Triton X-114, a plasma
membrane protein kit, cell surface protein biotinylation,
total protein extraction, and lipid-based protein immobili-
zation flow cell. Digested protein extracts were analyzed by
nanoflow liquid chromatography tandem mass spectrome-
try. Then the identified proteins were categorized according
to cellular location using their gene ontology annotation
and by prediction of transmembrane helices in the
sequence. This information was used to estimate the
amount of membrane proteins identified.
Results By combining the results from all extraction
procedures, the total number of membrane proteins identi-
fied from the human islets was increased, accentuating that
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a combination of methods usually gives a higher coverage
of the proteome. A total of 1,700 proteins were identified
(≥2 unique peptides), and 735 of these proteins were
annotated as membrane proteins while 360 proteins had at
least one predicted transmembrane helix. The extraction
method using phase separation with Triton X-114 yielded
both the highest number and the highest proportion of
membrane proteins.
Conclusion This study gave an enhanced characterization
of the human islet membrane proteome which may
contribute to a better understanding of islet biology.
Keywords Human islets of Langerhans . Proteomics .
Membrane protein extraction .Mass spectrometry .
SDS-PAGE . FTICR MS/MS
Introduction
The islets of Langerhans, constituting 1% to 2% of the
pancreas mass, compose the endocrine part of the pancreas.
The main cell types in the islets are the insulin and amylin
producing beta-cells as well as the glucagon producing
alpha-cells, while somatostatin producing delta-cells and
pancreatic polypeptide producing cells are less abundant [1,
2]. Hormones released from these cells serve complex,
synergistic or antagonistic, roles maintaining the homeo-
stasis of plasma glucose levels in the body under normal
conditions. In diabetes mellitus, there is an absolute (type 1
diabetes mellitus) or relative insulin deficit (type 2 diabetes
mellitus) [3], leading to chronic hyperglycemia and other
metabolic perturbations.
Pancreatic beta-cells are destroyed in patients with type
1 diabetes as a result of selective autoimmune destruction
[4]. In patients with type 2 diabetes, insulin resistance is
usually combined with a progressive loss of beta-cell
function and mass occurring over time [5]. Insulin
resistance in peripheral tissues challenges the beta-cells to
produce and secrete increased amounts of insulin to
maintain normoglycemia. The insulin resistance and the
gradual loss of beta-cell function finally lead to insufficient
insulin release and chronic hyperglycemia. The prolonged
exposure of beta-cells to high glucose levels (glucotoxicity)
further reduces the capacity of beta-cells to secrete insulin,
thus creating a vicious circle [6]. The mechanism causing
the loss of beta-cell function and mass in type 2 diabetes is
still debated [3].
In order to better understand the pathophysiology of
both type 1 and type 2 diabetes mellitus, an improved
characterization of the islets of Langerhans and their
response to glucotoxicity is essential. With these aims,
several proteomic studies have been conducted ([7, 8] for
recent reviews). The majority of previous proteomic
studies have been performed on cultured insulinoma cells
[9–13] or mouse islets [14–18]. However, these model
systems might not reflect the human systems [19, 20]. Two
proteomic studies have previously been performed on
human pancreatic islets. The first aimed at creating a two-
dimensional gel electrophoresis (2-DE) reference map of
human islets and generated 66 unique protein identities
[21]. Then, Metz et al. [22] performed a global character-
ization of total extracts from human islets of Langerhans
using two-dimensional liquid chromatography (LC) tan-
dem mass spectrometry (MS/MS). Our proteomic study is
focused on characterizing the membrane proteome of
human islets. Membrane proteins play a critical role in
cellular function and currently account for about 70% of
all known pharmaceutical drug targets [23]. A better
definition of the membrane proteome of human islets
would add important knowledge for our endeavors in
finding and better understand new targets in human islets,
which may lead to new therapies aiming at preserving or
even increasing the number of beta-cells. It may also help
in discovery of novel biomarkers, both for measurement of
circulating levels and for imaging approaches, which can
reflect beta-cell mass and function.
In the present study, we have used isolated human
pancreatic islets to characterize the membrane proteome.
For an improved membrane islet protein profiling, five
different extraction procedures have been used and com-
pared followed by identification of membrane proteins by
nanoflow reversed phase LC coupled with Fourier trans-
form ion cyclotron resonance (FTICR) MS/MS.
Materials and Methods
Human Islets of Langerhans
Pancreatic tissues that were not used for transplantation
were obtained from multiorgan donors with informed
consent either from the organ donor registry or from
relatives. Approval for the conduct of this study was
obtained from the local ethics committee. Human pancre-
atic islets were isolated, as described previously [24], at
Uppsala University, using intraductal collagenase perfusion,
automated digestion filtration, islet continuous gradient
purification, and subsequent islet culture for 6 days in
CMRL 1066 (AppliChem, GmbH, Darmstadt, Germany)
supplemented with 50 μg/mL gentamycin and 0.25 μg/mL
fungizone (GIBCO BRL) at 37°C (5% carbon dioxide).
Islet yield and purity were determined in a standardized
procedure using a digital analysis system (Cellimag,
Uppsala, Sweden). All analyzes were performed on snap
frozen islet tissue (≥90% pure) from the same donor. The
islets were kept at −80°C until analysis.
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Protein Extraction Procedures
Five different approaches were tested for solubilization of
membrane proteins from human pancreatic islets (Fig. 1),
including total protein extraction, phase separation using
Triton X-114, plasma membrane protein extraction, cell
surface protein biotinylation, and lipid-based protein im-
mobilization (LPI).
Total Protein Extraction Human pancreatic islets (45 mg,
corresponding to 20,000 islets equivalents (IEQ)) were
dissolved in lysis buffer containing 7 M urea, 2 M thiourea,
30 mM tris(hydroxymethyl)aminomethane (Tris), 4% 3-[(3-
cholamidopropyl) dimethylammonio]-1-propanesulfonate,
and 1% (v/v) protease inhibitor cocktail Set III (Calbiochem,
Merck Chemicals, Nottingham, UK). The cells were soni-
cated using a Soniprep 150 Ultrasonic Disintegrator (MSE
Limited, London, UK) on ice/water bath for four 10-s bursts
with 20-s intervals between each burst. Cell debris was
removed by centrifugation at 15,000×g for 30 min at 4°C,
and the supernatant was transferred to new vials. A fraction
of the protein extract (100 μg protein concentration) was
purified and concentrated using the ProteoExtract kit
(Calbiochem, Merck Chemicals) dissolved in NuPAGE
lithium dodecyl sulfate (LDS) sample buffer (Invitrogen
Limited, Paisley, UK) containing 50 mM 1,4-dithiothreitol
(DTT) and stored at −80°C pending analysis.
Phase Separation Using Triton X-114 Proteins from human
pancreatic islets (57 mg, corresponding to 25,000 IEQ)
were extracted using the ReadyPrep extraction kit, mem-
brane 1 (Bio-Rad, Hercules, CA, USA), which is based on
the method described by Bordier [25], according to
instructions from the manufacturer. Briefly, islets were
sonicated in a Triton X-114 buffer containing protease
inhibitors using a Soniprep 150 Ultrasonic Disintegrator
(MSE Limited) on ice/water bath for four 10-s bursts with
20-s intervals between each burst. Temperature-dependent
phase partitioning and centrifugation at 13,000×g for
10 min at room temperature (RT) generated membrane
proteins in a hydrophobic phase (Triton X-114) and an
insoluble pellet. A fraction of each protein extract (25 μg
protein concentration) was purified and concentrated using
the ProteoExtract kit (Calbiochem) dissolved in LDS
sample buffer (Invitrogen) containing 50 mM DTT and
stored at −80°C pending analysis.
Plasma Membrane Protein Extraction Kit Using Lectin
Binding of Microsomes Human islets (190 mg,
corresponding to 80,000 IEQ) were treated with the
Qproteome plasma membrane protein kit (Qiagen Group,
Valencia, CA, USA) according to instructions from the
manufacturer. Briefly, the islet cells were mechanically
disrupted, in the provided lysis buffer containing protease
inhibitors, by injecting and rejecting the lysate for 20 times
in a disposable needle and syringe. Then, the lysate was
centrifuged at 12,000×g for 20 min at 4°C, and the pellet
was ejected. Plasma membrane microsomes were extracted
from the supernatant by addition of magnetic beads coated
with lectins (biotinylated wheat germ agglutinin, concanav-
alin A, and Lens culinaris). After washing, plasma
membrane vesicles were eluted under native conditions.
The protein extract (25 μg protein concentration) was
purified and concentrated using the ProteoExtract kit
Fig. 1 Schematic presentation
of the workflow for the analysis
of proteins from human pancre-
atic islets in this study
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(Calbiochem) dissolved in LDS sample buffer (Invitrogen)
and stored at −80°C pending analysis.
Cell Surface Protein Biotinylation Human islets (127 mg,
corresponding to 55,000 IEQ) were treated with the Cell
Surface Protein Isolation Kit (Pierce, Rockford, IL, USA)
according to instructions from the manufacturer. Cell
surface proteins on intact islet cells were labeled with EZ-
Link Sulfo-NHS-SS-Biotin. Cells were lysed with a mild
detergent containing protease inhibitors using a Soniprep
150 ultrasonic disintegrator (MSE Limited) on ice/water
bath for five 10-s bursts with 30-s intervals between each
burst. The labeled proteins were isolated using a NeutrA-
vidin agarose spin column, and the proteins were eluted
after incubation with 50 mM DTT in LDS sample buffer
(Invitrogen) and stored at −80°C pending analysis.
Lipid-Based Protein Immobilization Flow Cell Crude mem-
brane extracts were prepared from human pancreatic islets
(68 mg, corresponding to 30,000 IEQ) by addition of 10 mM
NaHCO3 and Dounce homogenization followed by centri-
fugation at 10,000×g, at 4°C for 10 min. Addition of
100 mM Na2CO3 to the supernatant containing the crude
membranes removed peripheral membrane proteins, and the
solution was centrifuged at 50,000×g, at 4°C for 90 min. The
pelleted crude membrane extracts were diluted in buffer
(10 mM Tris–HCl, 300 mM NaCl, pH 8) and tip sonicated to
form proteoliposomes and then immobilized on the surface
of the LPI flow cell (Nanoxis, Gothenburg, Sweden),
followed by tryptic digestion of membrane proteins in the
proteoliposomes and elution of peptides from the flow cell.
The peptide extract was dried in a vacuum centrifuge (DNA
120 SpeedVac, ThermoSavant) and dissolved in 0.2% formic
acid prior to LC-MS/MS analysis.
Prior to freezing, a small aliquot from each extract was
removed for determination of protein concentration. The
aliquots were treated with the ProteoExtract protein
precipitation kit (Calbiochem, Merck Chemicals) to remove
chemicals that could interfere with the protein assay.
Proteins were solubilized in phosphate buffered saline,
and the protein concentration was determined using
bicinchoninic acid protein assay kit (Pierce).
SDS-PAGE
Extracted proteins were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
The extracts dissolved in NuPAGE LDS sample buffer
(Invitrogen) containing 50 mM DTT were thawed, heated
to 56°C for 10 min, and separated on 10% Bis-Tris
NuPAGE gels, 1 mm, ten wells (Invitrogen) with 1× MES
buffer (Invitrogen, 50 mM 2-(N-morpholino)ethanesul-
fonic, 50 mM Tris base, 1 mM EDTA, 3.5 mM SDS at
pH 7.3) at 200 V for 37 min. The gels were stained using
SimplyBlue Coomassie SafeStain (Invitrogen).
In-Gel Protein Digestion
Each SDS-PAGE lane was excised and cut in 15 pieces and
subjected to in gel tryptic digestion as previously described
by Shevchenko et al. [26], with some minor modifications.
Briefly, the gel pieces were destained by washing twice in
25 mM NH4HCO3 in 50% CH3CN. Gel pieces were dried
in a vacuum centrifuge and incubated with 10 mM DTT in
25 mM NH4HCO3 for 40 min at 56°C followed by a dark
incubation with 55 mM iodoacetic acid in 25 mM
NH4HCO3 for 30 min at RT. Then, the gel pieces were
washed twice in 25 mM NH4HCO3 in 50% CH3CN and
once in 25 mM NH4HCO3 in 50% CH3OH and dried in the
vacuum centrifuge. Digestion buffer (50 mM NH4HCO3,
10 ng/μL trypsin) was added to the dried gel pieces
followed by incubation at 37°C overnight. Peptides were
extracted in 50% CH3CN containing 1% CH3COOH twice,
and the supernatants were pooled and evaporated to dryness
in the vacuum centrifuge. Prior to MS analysis, the peptides
were reconstituted in 0.1% HCOOH.
Nanoflow LC-MS/MS FTICR
Sample injections were made with an HTC-PAL autosampler
(CTC Analytics AG, Zwingen, Switzerland) connected to an
Agilent 1,100 binary pump (Agilent Technologies, Palo Alto,
CA, USA). The peptides were trapped on a precolumn (45×
0.075 mm i.d.) and separated on a reversed phase column,
200×0.050mm. Both columns are packed in-house with 3 μm
Reprosil-Pur C18-AQ particles. The flow through the analyt-
ical column was reduced by a split to approximately 100 nL/
min. A 40-min gradient 10–50% CH3CN in 0.2% COOH was
used for separation of the peptides. For more details, see [27].
The nanoflow LC-MS/MS were performed on a hybrid
linear ion-trap FTICR mass spectrometer equipped with a
7-T ICR magnet (LTQ-FT, Thermo Electron, Bremen,
Germany). The spectrometer was operated in data-
dependent mode, automatically switching to MS/MS mode.
MS-spectra were acquired in the FTICR, while MS/MS-
spectra were acquired in the LTQ-trap. For each scan of
FTICR, the six most intense, doubly or triply charged, ions
were sequentially fragmented in the linear trap by collision-
induced dissociation. Between scans, an exclusion time of
6 s for the same ion species was selected.
Database Search and Data Analysis
All MS/MS samples were analyzed using Mascot v 2.2.1
(Matrix Science, London, UK) and X!Tandem (www.
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thegpm.org; version 2007.01.01.1). X!Tandem was set up
to search a subset of the UniProtKB/Swiss-Prot database
(http://www.expasy.ch/sprot/) also assuming trypsin. Mas-
cot was set up to search the UniProtKB/Swiss-Prot 55.3
database (selected for Homo sapiens, 19372 entries).
Mascot and X!Tandem were searched with a fragment ion
mass tolerance of 0.50 Da and a parent ion tolerance of
5.0 ppm. Iodoacetamide derivative of cysteine (for total protein
extraction, hydrophobic phase, insoluble phase, plasma mem-
brane protein extraction, and cell surface protein biotinylation
samples) was specified in Mascot and X!Tandem as a fixed
modification. Oxidation of methionine was specified in
Mascot and X!Tandem as a variable modification.
Criteria for Protein Identification Scaffold (version Scaf-
fold_2_05_02, Proteome Software Inc., Portland, OR, USA)
was used to validate MS/MS-based peptide and protein
identifications. Peptide identifications were accepted if they
could be established at greater than 95.0% probability as
specified by the PeptideProphet algorithm [28]. Protein
identifications were accepted if they could be established at
greater than 99.0% probability and contained at least two
identified unique peptides (i.e., identified peptide sequences
that are unique to an individual parent protein sequence).
Protein probabilities were assigned by the ProteinProphet
algorithm [29]. Proteins that contained similar peptides and
could not be differentiated based on MS/MS analysis alone
were grouped to satisfy the principle of parsimony.
When the rule for protein identification was applied (≥2
unique peptides at ≥95% level of confidence), the false
discovery rate of protein identifications was 0.64%. Further-
more, according to the ProteinProphet algorithm [29], no
identified protein had a probability of less than 99.8%.
The GO TermMapper (http://go.princeton.edu/cgi-bin/
GOTermMapper) was used to annotate the cellular location
of proteins.
Prediction of transmembrane helices (TMH) in proteins
was performed by CBS prediction servers (www.cbs.dtu.
dk/services/TMHMM/).
Proteins identified in digests from “blank” gel pieces,
not containing any islet protein extracts, were considered
contaminants and removed from the list of proteins; these
proteins all correspond to different keratins (e.g., keratin,
type II cytoskeletal 1, 5, 6A, 7, 8, and 9; keratin, type I
cytoskeletal 10, 13, 14, 16, 18, and 19 as well as keratin,
type II cytoskeletal two epidermal).
Results and Discussion
This study focuses on characterization of the membrane
fraction of human islets of Langerhans and especially on
proteins located at the plasma membrane and cell surface
since most drug targets have been suggested with this
cellular location [30]. For an improved membrane protein
profiling of the islets, five distinct protein extraction
approaches were used including total extraction, phase
separation using triton X-114 (enriching membrane proteins
in a hydrophobic phase and an insoluble pellet), a plasma
membrane protein kit, cell surface protein biotinylation, and
LPI flow cell, followed by LC-MS/MS analysis (Fig. 1).
In total, 1,700 proteins from pancreatic islets were
identified in this study, and 930 of these proteins were
confirmed by at least two different extraction methods
(Supplementary Table 1).
The identified proteins were assigned to cellular location
using gene ontology (GO) annotations, and the presence of
TMH in their sequence was predicted in order to analyze
the performance of the different extraction methods (Fig. 2;
Table 1). The total amount of unique peptides and proteins
identified by each individual protein extraction procedure
showed that the highest number of proteins (1,136) was
detected when analyzing total protein extracts of the islets
(Table 1). One reason is that the total extract was applied in
fourfold total protein concentration compared to the other
methods. Since the same starting amount of islet tissue
generally gave a fourfold protein yield when using total
protein extraction compared to the membrane protein
enriching methods, this ratio was kept in the mass
spectrometric analysis. If the total extraction procedure
could identify a similar amount of membrane proteins as
the membrane enriching methods, this would be an easy
and straightforward method to use. Thus, these methods
were further compared. By combining all unique proteins
identified after each membrane enriching extraction proce-
dure, a total of 1,348 proteins were identified, and 564 of
these proteins were not identified using only total protein
extraction (Fig. 3). As anticipated, a high proportion
(61.2%) of membrane proteins was present among the 564
proteins exclusively identified by the membrane enriching
methods. Furthermore, only 18.5% of the 342 proteins
exclusively identified in the total extract were membrane
proteins. These results highlight that in the analysis of proteins
in complex biological samples, like the islets of Langerhans,
sample preparation and pre-fractionation can increase the
amount of identified proteins with specific properties, which
are favored by the sample preparation method. By combining
results from several protein extraction procedures, a more
complete picture of the proteome can be created [31].
However, it is not always possible to combine results
from different proteomic procedures, e.g., due to limited
amounts of biological sample, costs, and/or time consid-
erations. Thus, the most suitable method has often to be
selected. The hydrophobic phase extraction yielded the
highest proportion of proteins annotated to membrane,
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plasma membrane, and cell surface, compared with all other
extraction methods (Table 1). Furthermore, the presence of
TMH in the identified protein sequences was predicted,
showing that the LPI flow cell method extracted the highest
proportion (42%) of these TMH proteins (Table 1).
The four extraction methods with the highest proportion
of membrane proteins (that is, the hydrophobic phase of
Triton X-114 extraction, plasma membrane protein extrac-
tion, cell surface protein biotinylation, and LPI flow cell)
were further compared by determining the number of
protein identities overlapping between the methods. It was
evident that the hydrophobic phase yielded the highest
number of proteins that were only identified by this
method, both when comparing the number of plasma
membrane proteins (Fig. 4a) as well as TMH proteins
(Fig. 4b). Unexpectedly, the methods designated to enrich
plasma membrane proteins as well as cell surface proteins
extracted relatively few uniquely identified plasma mem-
brane proteins (Fig. 4a). The plasma membrane extraction
kit is based on selective lectin binding of the carbohydrates
on plasma membrane protein vesicles. This selective
interaction might have been reduced by any interfering
protein or if a proportion of the plasma membrane vesicles
were turned inside-out in the lysis procedure (i.e., leaving
the carbohydrate moiety of the plasma membrane proteins
hidden inside of the vesicle). In addition, high abundant
soluble proteins might have been trapped inside the vesicles
and extracted together with the plasma membrane proteins,
explaining the low enrichment of plasma membrane
proteins.
The limited success of the cell surface biotinylation kit
could be explained since labeling may have been prevented
by steric hindrance, lack of primary amines in the protein
sequences extending from the cells, and/or a minimal
sequence with extracellular exposure. Furthermore, this kit
was developed for the analysis of cell cultures and not for
tissue samples; thus, any lysis of cells etc. may cause
intracellular proteins to be available for biotinylation,
resulting in reduced proportion of membrane proteins in
this extract.
In this study, the only extraction procedure that did not
involve a gel separation step prior to LC-MS/MS was the
LPI flow cell method. This method yielded the highest
percentage of TMH proteins and the second highest
percentage of membrane proteins (Table 1). However, due
to the total amount of proteins identified by this method
Fig. 2 Extraction efficiency of proteins from different cellular
locations. Pie chart showing cellular location of identified proteins
after the different protein extraction methods. The percentages were
determined using the GO TermMapper, cellular component ontology.
Protein identification, at >99%, required at least two unique peptides,
at ≥95% confidence level, detected by LC-FTICR MS/MS, searched
against the human Swiss-Prot database using MASCOT and X!
Tandem
200 Clin Proteom (2010) 6:195–207
being quite low, a low coverage of the islet membrane
proteome still was given. The low protein yield of this
method could at least partly be explained by the fact that
this extract was run in a single LC-MS/MS run after elution
of peptides from the flow cell, while all the other extraction
methods involved a protein separation step on SDS-PAGE
resulting in 15 fractions, each digested and analyzed
separately by LC-MS/MS. In order to increase the yield
of the peptide extract eluted from the LPI flow cell in future
analyses, a second separation step on peptide level could be
added.
Several characteristic hormones of the islet of Langer-
hans were detected in this study including glucagon,
insulin, islet amyloid polypeptide, and somatostatin. These
hormones are secreted molecules and are best represented
in the total extraction method (Supplementary Table 1).
These results emphasize that soluble proteins are unfavored
by the membrane protein enriching methods.
Furthermore, 61 proteins with receptor function were
identified (Table 2). The hydrophobic extraction method
yielded most of the identified receptors (52 proteins, 85%).
By combining receptors identified in the hydrophobic phase
and the insoluble phase (since they are different phases of
the same Triton X-114 extraction), 93% of the receptor
proteins, identified in this study, are covered. Generally, the
highest amount of unique peptides and the highest sequence
coverage of the receptors were also identified by the
hydrophobic phase method (Table 2).
A detailed description of these receptors is beyond the
scope of this article; however, a few receptor classes,
including integrins and CD proteins, merit commenting due
to their potential involvement in beta-cell destruction or the
pathogenesis of diabetes. Integrins are integral receptors,
composed of an alpha and beta chain, that mediate
attachment between a cell and the tissues surrounding it,
which may be other cells or the extracellular matrix (ECM).
They also play a role in cell signaling and thereby define
cellular shape, mobility, and regulate the cell cycle.
Integrins also transduce information from the ECM to the
cell as well as reveal the status of the cell to the outside,
allowing rapid and flexible responses to changes in the
environment [32]. There are many types of integrins, and
many cells have multiple types on their surface. Integrins
can bind components such as fibronectin, vitronectin,
collagen, and laminin. Furthermore, increased levels of
several integrins have been found in microvessels isolated
from patients with diabetes mellitus [33, 34].
The CD proteins are members of the transmembrane four
superfamily. Most of these members are cell surface
glycoproteins that are characterized by the presence of four
hydrophobic domains. The proteins mediate signal trans-
duction events that play a role in the regulation of cell
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been indicated that the progression of islet destruction in
type 2 diabetes islets may be the result of specific changes
in pathway activation of signaling related to proliferation
and regeneration [36]. CD proteins are known to form
complexes with integrins to regulate cell motility in human
pancreatic adenocarcinoma [37]. Furthermore, the TSPAN8
gene belonging to the transmembrane four superfamily has
been suggested to contain a risk loci for type 2 diabetes
making it possible that variation in this protein may
biologically influences pancreatic beta-cell function [38].
The successful identification of these receptor proteins
indicates that hydrophobic phase extraction is a good
method for further studies of these membrane proteins with
implications in beta-cell dysfunction or the diabetic
pathology. However, as the ATP-binding cassette transport-
er sub-family C member eight protein exemplifies, it is
likely that the detergent Triton X-114 is unable to solubilize
this protein sufficiently, with its six transmembrane helices,
and therefore, the protein ended up in the insoluble phase
(Table 2). Nevertheless, some highly hydrophobic proteins,
e.g., neutral amino acid transporter B(0), with nine
transmembrane helices, could still be identified in the
hydrophobic phase of Triton X-114 extracts.
Even so, this study failed to identify some receptors with
important functions in the islet cells, for example, the
insulin receptor, somatostatin receptor [39], and epidermal
growth factor receptor [40]. One explanation can be that
these receptors are relatively low abundant and due to the
complex mixture of proteins in a biological sample, which
has a vast dynamic range of protein amounts [41], the
analytic ability of mass spectrometry still makes it hard to
detect the low abundant proteins. For detection of very low
abundant proteins of the cells, more focused techniques, for
example, immunoprecipitation followed by MS/MS identi-
fication or antibody based detection methods, are required.
A recent study [42] has utilized high throughput immuno-
histochemistry on tissue microarrays for detection of
proteins expressed in pancreatic islets. The Swedish Human
Protein Altas [43] (www.proteinatlas.org) was searched for
proteins with a differential expression in the endocrine
islets compared with the surrounding exocrine pancreatic
tissue. They identified five novel endocrine markers with
expression in islet cells, both in pancreatic tissues and in
vitro cultured islets including, beta-2-microglobulin,
glyceraldehyde-3-phosphate dehydrogenase, SUN domain-
containing protein 3 (SUNC1), tetraspanin-7, and ubiquitin
carboxyl-terminal hydrolase isozyme L1. These suggested
Fig. 4 Venn diagram comparing the numbers and overlap of proteins
identified after different membrane protein extractions of human
pancreatic islets. a The number of proteins identified as plasma
membrane proteins according to gene ontology annotation. b The
number of proteins predicted with at least one transmembrane helix in
their protein sequence. Protein identification, at >99%, required at
least two unique peptides, at ≥95% confidence level, detected by LC-
FTICR MS/MS, searched against the human Swiss-Prot database
using MASCOT and X!Tandem. Hydrophoboc phase the hydrophobic
phase of Triton X-114 phase separation, Plasma MPE plasma
membrane protein extraction, Cell SPB cell surface protein biotinyla-
tion, LPI flow cell lipid-based protein immobilization flow cell
Fig. 3 Venn diagram comparing the numbers and overlap of unique
proteins from human pancreatic islets identified after total protein
extraction and when all membrane protein enriching extraction
methods were combined. The percentages of membrane proteins
(MP) are also given. Protein identification, at >99%, requiring at least
two unique peptides, at ≥95% confidence level, detected by LC-
FTICR MS/MS, searched against the human Swiss-Prot database
using MASCOT and X!Tandem
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endocrine markers were also identified in our study
(Supplementary Table 1), with exception of SUNC1, which
may be explained by that SUNC1 had a significantly lower
protein level in isolated islets [42], used in our study,
compared with that of islets in pancreatic tissues.
The two previous proteomic studies of isolated human
pancreatic islets have both characterized total protein extracts.
Ahmed et al. [21] used 2-DE and MALDI-TOF-MS and
detected 744 protein spots in the gels, 130 of these proteins
were identified, and they corresponded to 66 unique
proteins. All these proteins, with exception of the glutamate
dehydrogenase 2 (mitochondrial), were confirmed in our
study. The study by Metz et al. [22] used two-dimensional
LC separations coupled with ion-trap MS/MS for a global
proteomic characterization of human islets and identified
3,365 proteins (≥2 unique peptides) against the human
International Protein Index (IPI) database [44]. In our study,
focusing on the membrane proteome, the MS/MS data were
searched against the human UniProtKB/Swiss-Prot (Sprot)
curated protein sequence database, providing a high level of
annotation, a minimal level of redundancy, and a high level
of integration with other databases. The present study only
accepted peptide and protein identifications based on
relatively strict criteria of the Prophet algorithms [28, 29].
The use of different experimental procedures and search
criteria is a likely explanation for the different number of
identified proteins in these studies. Nevertheless, when the
protein identities from this study were converted to IPI
entries, 1,169 proteins overlapped with the identities in the
study by Metz and coworkers [44], while 531 proteins were
uniquely identified in our study. Among the proteins
identified only in this study, 269 were membrane proteins
and 156 contained transmembrane helices. Thus, our study
confirms some previous findings and adds further proteins to
the proteomic profile of human islets of Langerhans.
Most previous diabetes-related proteomic studies have
been performed on pancreatic beta-cell lines, especially
mouse insulinoma, MIN-6 cells [10], and rat insulinoma,
INS-1 cell clones [9, 11, 12] as surrogates for primary β-
cells because they are more abundant and homogenous.
However, their expression profile can be significantly
different from that of primary β-cells [19]. On the other
hand, proteomic studies on human islets are influenced by
the variability introduced by individual changes and by the
less controlled conditions that can be applied for the
procurement of tissues from humans, relative to cell lines
and to laboratory animals. Thus, the advances in producing
a reverted immortalized human beta-cell line RNATK-15
[45] might be a valuable source for future investigations in
the pathology of diabetes, with the prerequisite that their
expression profiles can be confirmed to be similar to the
beta-cells in human islets of Langerhans, as indicated in a
recent study by Jin et al. [13].
Conclusions
We conclude that the choice of method for extraction of
membrane proteins from human islets of Langerhans will
influence the number and identity of proteins detected in
the proteomic analysis. Combining the results from varying
extraction procedures enhanced the total number of mem-
brane proteins identified, since every extraction method
used contributed with uniquely identified membrane pro-
teins. However, the hydrophobic phase of Triton X-114
phase separation was the extraction method yielding both
the highest number and the highest proportion of membrane
proteins. The list of proteins presented here contributes to
the characterization of the human islet membrane proteome,
which can be used as a reference in further studies and
clinical applications in the diabetic research area.
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